Moderna Has Lost 94% Of Its Value Over Four Years. Is It A Sell?

1 day ago · Moderna stock peaked at 497.49 in August 2021, at the height of the Covid pandemic. Since then, the stock has fallen precipitously, down 94% over the past four years. Is Moderna Stock A Buy Or A Sell?

94%
OFF

Moderna Has Lost 94% Of Its Value Over Four Years. Is It A Sell?

2 weeks from now

investors.com

94%
OFF

Moderna Has Lost 94% Of Its Value Over Four Years. Is It A Sell?

2 weeks from now

Moderna stock took a beating in January after the company slashed its outlook for 2024 and 2025 and missed the mark in a CMV study. ... Moderna Has Lost 94% Of Its Value Over Four Years.

msn.com

94%
OFF

Moderna Has Lost 94% Of Its Value Over Four Years. Is It A Sell?

2 weeks from now

1 day ago · Moderna Has Lost 94% Of Its Value Over Four Years. Is It A Sell? Moderna stock took a beating in January after the company slashed its outlook for 2024 and 2025 and missed …

yahoo.com

$18
OFF

Moderna's MRNA Technology Looks Undervalued Despite Lower …

2 weeks from now

1 day ago · Moderna's massive covid vaccine sales and prepayments left it with $18.2 billion in cash at the end of 2022, but that balance is steadily shrinking due to previous share …

morningstar.com

85%
OFF

Is Moderna Stock A Buy? - The Motley Fool

2 weeks from now

Dec 20, 2024 · The company's revenue, earnings, and stock price have been moving in the wrong direction for the past three years, a period during which the biotech has lost 85% of its value.

fool.com

17%
OFF

Moderna Inc (MRNA) Stock Price & News - Google Finance

2 weeks from now

Moderna stock plunges nearly 17% after company lowers 2025 sales forecast by $1 billion. 1 day ago. ... Moderna Has Lost 94% Of Its Value Over Four Years. Is It A Sell? Financials.

google.com

17%
OFF

Moderna Stock Plummets 17% On 2025 Sales Guidance Slash

2 weeks from now

22 hours ago · The Zacks Consensus Estimate for 2025 revenues is $2.94 billion. In the past year, the stock has plunged nearly 67% ... Moderna reiterated its stance to launch 10 new …

nasdaq.com

20%
OFF

Moderna Stock Falls 20% In A Month: Time To Sell Or Hold?

2 weeks from now

Oct 16, 2024 · In the past month, the stock has underperformed the industry’s 2.3% fall, as seen in the chart below. It has also underperformed the sector and the S&P 500. Shares of …

nasdaq.com

39%
OFF

Moderna Stock Down 39% In Three Months: Buy The Dip Or Wait?

2 weeks from now

Dec 23, 2024 · Estimates for Moderna’s 2024 loss per share have improved from $9.94 to $9.30 in the past 60 days.During this timeframe, estimates for 2025 loss per share have increased …

nasdaq.com

2%
OFF

Moderna Stock Extends Losses Amid Flurry Of Downgrades, Price …

2 weeks from now

Sep 16, 2024 · Moderna stock tumbled 2% to 68.28 on Friday. That followed a 12.4% dive on Thursday. It's not the first time Moderna's financial outlook has weighed on shares, William …

investors.com

20%
OFF

Moderna Stock Falls 20% In A Month: Time To Sell Or Hold?

2 weeks from now

Oct 16, 2024 · In the past month, MRNA stock fell more than 20% after management provided an update on its business outlook for the next four years. It also announced plans to slash its …

yahoo.com

$160
OFF

Moderna Stock Falls To $160. Should You Buy, Sell Or Hold?

2 weeks from now

Jan 28, 2022 · Moderna stock (NASDAQ: MRNA) has lost almost a third of its value thus far in 2022 and currently trades at about $160 per share. The sell-off is driven by two broad factors. …

nasdaq.com

$38
OFF

Is Investing In Moderna Stock (NASDAQ:MRNA) Simply Dead …

2 weeks from now

Nov 20, 2024 · It doesn’t take too much math to realize that a company that trades at around $38 and is forecasted to lose $28.71 per share over the next four years is in somewhat of a …

businessinsider.com

94%
OFF

Moderna Nears Its First Breakout In Over A Year After Launching …

2 weeks from now

Mar 11, 2024 · Related news Moderna Has Lost 94% Of Its Value Over Four Years. Is It A Sell? 1/14/2025 Moderna stock took a beating in January after the company slashed its outlook for …

investors.com

20%
OFF

Moderna Stock Falls 20% In A Month: Time To Sell Or Hold? - MSN

2 weeks from now

The company reduced its overall R&D budget for the next four years (2025 to 2028) by nearly 20% to $16 billion. To meet these numbers, management decided to discontinue five pipeline …

msn.com

87%
OFF

Moderna (MRNA) Stock Declines 87% In Three Years: 3 Key Points

2 weeks from now

Nov 28, 2024 · On November 30th, exactly 3 years ago, Moderna’s (MRNA) stock was priced at $352.43, but after losing 87.69% of its value, MRNA stock is priced at $43.50. This downturn …

nasdaq.com

FAQs about Moderna Has Lost 94% Of Its Value Over Four Years. Is It A Sell? Coupon?

Is Moderna stock a sell?

Moderna Has Lost 94% Of Its Value Over Four Years. Is It A Sell? Moderna stock took a beating in January after the company slashed its outlook for 2024 and 2025 and missed the mark in a cytomegalovirus study. Please watch the video at Investors.com - How To Buy Stocks: IBD's Four Pillars Of Investing ...

Why did Moderna stock fall?

Moderna shares also toppled on Nov. 7 after the company beat third-quarter sales expectations, but kept its outlook for the year, indicating the beat stemmed from sales that typically would have occurred in the fourth quarter. The company also came up with surprise profit, but still expects losses in the future. ...

Will Moderna lose money in 4 years?

Analysts think Moderna will lose money for at least four years. Moderna 's (MRNA -20.49%) sales are slowing down, and Moderna stock is going down -- a lot. The coronavirus vaccine maker's shares plunged 21.2% through 10:20 a.m. ET Monday after it updated investors on its 2024 performance and released new guidance for 2025. ...

Why did Moderna mRNA stock fall 20%?

D espite giving the world one of the first and most widely used COVID-19 vaccines, shares of Moderna MRNA have lost significantly in the past couple of years due to declining sales amid low demand for the vaccine. In the past month, MRNA stock fell more than 20% after management provided an update on its business outlook for the next four years. ...

How much did Moderna lose in the fourth quarter?

For the fourth quarter, Moderna stock analysts project adjusted losses of $3.35 per share and $1.04 billion in sales. Sales are expected to dive again in the first quarter, in timing with the seasonal nature of Moderna's respiratory vaccines. Analysts call for a $3.23 per-share loss and $138 million in sales. ...

How much will Moderna sell in 4th quarter?

Sales expectations for Moderna have come down markedly over the last year. For the fourth quarter, analysts polled by FactSet currently project $990 million in sales. But the company's guidance suggests sales will actually come in much lighter than that, at $780 million. ...